Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
McKinsey
AstraZeneca
Chubb
UBS
Deloitte
Covington
Baxter
Cantor Fitzgerald

Generated: April 21, 2018

DrugPatentWatch Database Preview

NALFON Drug Profile

« Back to Dashboard

Which patents cover Nalfon, and what generic alternatives are available?

Nalfon is a drug marketed by Xspire Pharma and Dista and is included in two NDAs.

The generic ingredient in NALFON is fenoprofen calcium. There are nine drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the fenoprofen calcium profile page.
Drug patent expirations by year for NALFON
Pharmacology for NALFON
Medical Subject Heading (MeSH) Categories for NALFON
Synonyms for NALFON
(.+/-.)-m-Phenoxyhydratropic acid
(+-)-2-(3-Phenoxyphenyl)propionic acid
(+-)-m-Phenoxyhydratropic acid
(+/-)-Fenoprofen
(+/-)-m-phenoxyhydratropic acid
2-(3-Phenoxy-phenyl)-propionic acid
2-(3-phenoxyphenyl)-propionic acid
2-(3-Phenoxyphenyl)propanoic acid
2-(3-Phenoxyphenyl)propanoic acid #
2-(3-Phenoxyphenyl)propionic acid
2-(m-phenoxyphenyl)propionic acid
2-[3-(phenyloxy)phenyl]propanoic acid
29679-58-1
3-phenoxy-hydratropic acid
3-Phenoxyhydratropic acid
31879-05-7
34597-40-5
34597-40-5 (calcium salt, anhydrous)
4CH-007316
53746-45-5 (calcium salt, dihydrate)
879F057
AB00052197
AB00052197_05
AB00052197_06
AB00052197-04
AB0065019
AC1L1FPT
AC1Q5RW1
AK116448
AKOS005256238
alpha-(m-phenoxyphenyl)-propionic acid
alpha-(m-phenoxyphenyl)propionic acid
alpha-Methyl-3-phenoxybenzeneacetic acid
BDBM54705
Benzeneacetic acid, .alpha.-methyl-3-phenoxy-, (.+/-.)-
Benzeneacetic acid, |A-methyl-3-phenoxy-
Benzeneacetic acid, alpha-methyl-3-phenoxy-, (+-)-
BPBio1_000846
BRN 2118687
BSPBio_000768
C06997
calcium;2-(3-phenoxyphenyl)propanoic acid;hydrate
calcium;2-(3-phenoxyphenyl)propionic acid;hydrate
CCG-39009
CHEBI:5004
CHEMBL1297
cid_16219353
CTK4G3649
D02350
D03XYW
DB00573
Di-benzeneacetate, .alpha.-methyl-3-phenoxy-, calcium salt, dihydrate
DivK1c_000848
DL-2-(3-phenoxyphenyl)propionic acid
DR000588
DTXSID9023045
EINECS 249-770-1
EINECS 250-850-3
Epitope ID:139975
Feneprofen calcium salt dihydrate
fenoprofen
Fenoprofen (USAN/INN)
Fenoprofen [USAN:BAN:INN]
Fenoprofen [USAN:INN:BAN]
Fenoprofen calcium
Fenoprofen calcium hydrate
Fenoprofen Calcium Salt
Fenoprofen calcium salt dihydrate
Fenoprofen Dihydrate, Calcium Salt
Fenoprofene
Fenoprofene [INN-French]
Fenoprofeno
Fenoprofeno [INN-Spanish]
Fenoprofenum
Fenoprofenum [INN-Latin]
Fenopron (TN)
Feprona
GTPL4820
HMS1921B19
HMS2090G18
HMS2092B07
HMS502K10
HSDB 3328
Hydratropic acid, m-phenoxy-, (.+/-.)-
Hydratropic acid, m-phenoxy-, (+-)-
IDI1_000848
J-018559
KB-222002
KBio1_000848
KBio2_001732
KBio2_004300
KBio2_006868
KBio3_001860
KBioGR_001477
KBioSS_001732
Lilly 53838
Lilly 53858
Lilly-53858
LS-76362
M-8808
MCULE-2686503876
MFCD00072027
MolPort-003-666-345
N6-[2-[[4-(Diethylamino)-1-methylbu-tyl]amino]-6-methyl-4-pyrimidinyl]-2-methyl-4,6-qu-inolinediamine trihydrochloride
Nalgesic
NCGC00094887-01
NCGC00094887-02
NCGC00094887-03
NINDS_000848
NSC-757813
NSC757813
OR257314
Pharmakon1600-01501011
Prestwick0_000754
Prestwick1_000754
Prestwick2_000754
Prestwick3_000754
RDJGLLICXDHJDY-UHFFFAOYSA-N
SBI-0051632.P002
SCHEMBL3797
SPBio_001402
SPBio_002707
Spectrum_001252
SPECTRUM1501011
Spectrum2_001391
Spectrum3_000910
Spectrum4_001009
Spectrum5_001311
SR-05000001767
SR-05000001767-1
ST24027516
UNM-0000306101
Z4588

US Patents and Regulatory Information for NALFON

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Xspire Pharma NALFON fenoprofen calcium CAPSULE;ORAL 017604-003 Approved Prior to Jan 1, 1982 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Dista NALFON fenoprofen calcium TABLET;ORAL 017710-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Xspire Pharma NALFON fenoprofen calcium CAPSULE;ORAL 017604-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Xspire Pharma NALFON fenoprofen calcium CAPSULE;ORAL 017604-004 Jul 21, 2009 RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for NALFON

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Dista NALFON fenoprofen calcium TABLET;ORAL 017710-001 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Xspire Pharma NALFON fenoprofen calcium CAPSULE;ORAL 017604-003 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Xspire Pharma NALFON fenoprofen calcium CAPSULE;ORAL 017604-002 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Medtronic
Cerilliant
Deloitte
Express Scripts
QuintilesIMS
Cantor Fitzgerald
Farmers Insurance
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.